Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Paternal Methotrexate Exposure Not Tied to Adverse Pregnancy Outcomes

Scott Baltic  |  March 19, 2017

NEW YORK (Reuters Health)—A father’s exposure to methotrexate 90 days or less before conception “should not be of major concern,” researchers say. Prepregnancy paternal methotrexate exposure appears to confer no increased risk of major or minor congenital malformation, stillbirth or preterm birth in his offspring, their study found. Methotrexate is a first-line therapy for rheumatoid…

Filed under:Drug Updates Tagged with:birthMethotrexateparenthoodpregnancypreterm birth

How to Diagnose Antisynthetase Syndrome

How to Diagnose Antisynthetase Syndrome

Quretul Quresh, MD, & Stephen Lindsey, MD  |  March 17, 2017

Antisynthetase syndrome (AS) is strongly associated with the presence of antibodies to aminoacyl-transfer RNA (tRNA) synthetases (ARSs) that are implicated in the pathogenesis of myositis and interstitial lung disease (ILD). Antibodies against eight antisynthetases have been identified and are detected in 16–26% of patients with idiopathic inflammatory myopathies (IIM).1 Serum assays for five of these…

Filed under:ConditionsMyositisOther Rheumatic ConditionsResearch Rheum Tagged with:aminoacyl-transfer RNAAntisynthetase SyndromeClinicalDiagnosisinflammatoryInterstitial Lung DiseaseMyopathiesmyositisoutcomepatient careResearchrheumatologistrheumatologysyndromeTreatment

ACR Puts Forward Principles on Patient Access to Care

From the College  |  March 17, 2017

The ACR has partnered with the American Medical Association (AMA) and over a dozen stakeholder groups to create a set of 21 principles to reform prior authorization protocols. This coalition represents hospitals, medical groups, patients, pharmacists and physicians with a unified goal of creating a more patient-centered, streamlined and transparent process for prior authorization. According…

Filed under:From the CollegePractice Support Tagged with:AC&RAMAAmerican College of Rheumatology (ACR)American Medical Association (AMA)Practice Managementprior authorizationrheumatologistrheumatology

ACR Joins Opposition to Proposed Healthcare Replacement Bill as Written

Mary Beth Nierengarten  |  March 16, 2017

The ACR is joining a chorus of voices asking Congress to reconsider several key provisions in the proposed American Health Care Act (AHCA) that it feels could have a detrimental effect on patients. Characterized as a replacement to the Affordable Care Act (ACA), the AHCA eliminates a number of provisions found in the ACA, although…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Access to careAccess to medicationAffordable Care Act (ACA)American Association of Retired PersonsAmerican Health Care Act (AHCA)American Medical Association (AMA)Capping Medicaidhealthcare provisionsPrevention and Public Health Fund

Time to Rethink Inpatient Rehab After Knee Replacement?

Megan Brooks  |  March 14, 2017

NEW YORK (Reuters Health)—Inpatient rehabilitation did not lead to better mobility following total knee replacement compared with a home-based program in a randomized controlled trial (RCT) conducted in Australia. The findings do not support inpatient rehabilitation for adults undergoing uncomplicated total knee arthroplasty, conclude the authors in JAMA on March 14.1 “Normally, one study is…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:kneeknee arthroplastyrehabilitationtotal knee replacement

Spinal Underwear May Relieve Lower Back Pain

Lara C. Pullen, PhD  |  March 14, 2017

A recent study in nurses and healthcare professionals examined the efficacy of a novel ergonomic aid for managing low back pain. After a three-month trial, researchers found that the aid, Spinal Underwear, reduced low back pain, suggesting that musculoskeletal symptoms may be influenced by posture and somatization…

Filed under:ConditionsResearch Rheum Tagged with:Association of Rheumatology Professionals (ARP)Back painlow back painMusculoskeletal

U.S. Doctors in Training to Work Longer Hours Under New Guidelines

Andrew M. Seaman  |  March 13, 2017

(Reuters Health)—Days may get a lot longer for some doctors in training after the group that oversees medical education in the U.S. rolled back controversial rules limiting the number of hours first-year residents may work. Beginning July 1, doctors in their first year of training after medical school may once again care for patients for…

Filed under:Career DevelopmentEducation & TrainingProfessional Topics Tagged with:ACGMEmedical education

Brodalumab Approved for Plaque Psoriasis

Michele B. Kaufman, PharmD, BCGP  |  March 9, 2017

Brodalumab has received FDA approval for treating plaque psoriasis in adults, with a Boxed Warning against prescribing it for patients with a history of suicidal thoughts or behavior…

Filed under:Biologics/DMARDsDrug Updates Tagged with:brodalumabFDAFood and Drug Administrationplaque psoriasis

Moderate Alcohol Intake Decreases SLE Risk in Women

Arthritis Care & Research  |  March 8, 2017

Beer, wine, liquor—alcohol contains elements that suppress systemic inflammation, and its consumption has been linked to reduced risk of cardiovascular disease and RA. A recent analysis examined the effect of alcohol on SLE risk in women from the two Nurses’ Health Study cohorts. The results: Researchers found an inverse association between moderate alcohol consumption and SLE risk—with a 39% reduction in SLE risk among women who consumed about half a drink of alcohol daily…

Filed under:ConditionsSystemic Lupus Erythematosus

U.S. Republicans Unveil Plan to Dismantle Obamacare, Critics Pounce

Susan Cornwell & Yasmeen Abutaleb  |  March 7, 2017

WASHINGTON (Reuters)—Long-awaited legislation to dismantle Obamacare was unwrapped on Monday by U.S. Republicans, who called for ending health insurance mandates and rolling back extra healthcare funding for the poor in a package that drew immediate fire from Democrats. In a battle waged since the 2010 passage of the Affordable Care Act, Democratic President Barack Obama’s…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Affordable Care Act (ACA)Health InsuranceObamacarePatient Protection and Affordable Care Act

  • « Previous Page
  • 1
  • …
  • 189
  • 190
  • 191
  • 192
  • 193
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences